Table 1 Characteristics in Kawasaki disease patients with different feeding practices
Exclusive breastfeeding | Partial breastfeeding | Formula feeding | P | |
|---|---|---|---|---|
N (%) | 293 (51.6) | 223 (39.3) | 52 (9.2) | - |
Male, n (%) | 179 (61.1) | 142 (63.7) | 34 (65.4) | 0.754 |
Age of disease onset, months | 19.0 (11.0–33.0) | 18.0 (11.0–29.0) | 15.0 (9.7–25.8) | 0.544 |
Age > 6 months, n (%) | 257 (87.7) | 202 (90.6) | 49 (94.2) | 0.871 |
iKD, n (%) | 224 (76.5) | 177 (79.4) | 46 (88.5) | 0.142 |
IVIG resistance, n (%) | 16 (5.5) | 7 (3.1) | 3 (5.8) | 0.417 |
Delayed IVIG treatment, n (%) | 18 (6.1) | 20 (9.0) | 2 (3.8) | 0.296 |
WBC, × 109/L | 14.4 ± 5.4 | 15.1 ± 5.3 | 15.9 ± 8.2 | 0.109 |
C-reactive protein, mg/dl | 57.5 (33.0–93.1) | 69.1 (40.9–101.9) | 73.4 (44.8–98.6) | 0.037 |
Hemoglobin, g/L | 108.1 ± 9.7 | 108.8 ± 10.4 | 111.2 ± 8.7 | 0.141 |
Hematocrit | 0.33 ± 0.03 | 0.33 ± 0.03 | 0.33 ± 0.03 | 0.917 |
Platelet, × 109/L | 353 (289–432) | 369 (280–440) | 362 (294–425) | 0.951 |
Albumin, g/L | 38.9 ± 3.7 | 39.1 ± 3.8 | 39.2 ± 3.8 | 0.819 |
AST, U/L | 32.0 (26.0–47.1) | 31.1 (25.2–43.0) | 34.4 (28.1–50.7) | 0.141 |
ALT, U/L | 24.2 (14.4–63.7) | 25.3 (14.8–63.7) | 31.0 (18.5–105.7) | 0.110 |
Total bilirubin, umol/L | 5.5 (3.9–9.0) | 5.3 (3.6–7.9) | 5.2 (3.9–8.7) | 0.281 |
LDH, U/L | 421.8 ± 121.3 | 414.1 ± 115.9 | 442.3 ± 116.0 | 0.298 |
Cholesterol, mmol/L | 3.6 ± 1.1 | 3.6 ± 0.8 | 3.5 ± 0.7 | 0.632 |
Creatine kinase, U/L | 55.9 (39.8–83.2) | 50.8 (36.4–75.8) | 53.2 (38.3–76.6) | 0.241 |
Procalcitonin, ng/ml | 0.5 (0.2–1.7) | 0.6 (0.2–1.5) | 0.5 (0.2–2.2) | 0.791 |
Serum sodium, mmol/L | 134.6 ± 2.8 | 134.7 ± 2.8 | 134.5 ± 2.4 | 0.896 |
CALs, n (%) | 84 (28.7) | 57 (25.6) | 8 (15.4) | 0.128 |